Eric Roos - Grafton MA Christopher OReilly - Middleboro MA Ruben Chevere - North Attleboro MA Leon M. Wilkins - North Andover MA
Assignee:
Organogenesis, Inc. - Canton MA
International Classification:
C12M 134
US Classification:
4352883, 4352975, 4353054
Abstract:
A bioreactor has a base for defining a well, a dish with a membrane suspended in the base, and a lid with gas permeable membranes and self-sealing ports.
Diagnostics And Therapeutics For Diseases Associated With An Il-1 Inflammatory Haplotype
Gordon Duff - Sheffield, GB Angela Cox - Sheffield, GB Nicola Camp - Salt Lake City UT, US Franceso diGiovine - Sheffield, GB Kenneth Kornman - Newton MA, US Leon Wilkins - North Andover MA, US Hongmin Chen - Devens MA, US John Rogus - North Andover MA, US
International Classification:
C12Q001/68
US Classification:
435006000
Abstract:
Methods and kits for determining whether a subject has or is predisposed to developing a disease which is associated with IL-1 polymorphisms and assays for identifying therapeutics for treating and/or preventing the development of these diseases are provided.
Vincent Ronfard - West Newton MA, US Alan Tuck - Sherborne MA, US Leon Wilkins - North Andover MA, US
Assignee:
ORGANOGENESIS, INC. - Canton MA
International Classification:
A61Q 19/08 A61K 45/00 C12N 5/06 C12P 1/00
US Classification:
424085100, 435404000, 435041000
Abstract:
The invention is directed to compositions containing growth agents synthesized from cultured cells from skin. Skin cells such as keratinocytes and dermal fibroblasts are cultured in vitro in cell medium and in the course of culture the cultured cells synthesize and secrete agents into the cell medium. The medium containing agents are collected and incorporated into pharmaceutical or cosmetic preparations to treat an individual. The preparation is applied and has a rejuvenating effect on the cells and tissue.
Food Compositions And Methods Of Treating Periodontal Disease
Kenneth Kornman - Newton MA, US Leon Wilkins - North Andover MA, US
International Classification:
A61K 36/82 A61K 36/73 A61K 36/53
US Classification:
424729000, 424745000, 424765000, 424769000
Abstract:
The invention provides a method of alleviating a sign or symptom of periodontal disease in a subject, by administering to the subject a composition containing a natural compound which inhibits matrix metalloproteinase activity and interleukin-1 activity.
Diagnostics And Therapeutics For Diseases Associated With An Il-1 Inflammatory Haplotype
Gordon W. Duff - South Yorkshire, GB Kenneth S. Kornman - Newton MA, US Leon Wilkins - North Andover MA, US Hongmin Chen - Devens MA, US John Rogus - North Andover MA, US
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
Methods and kits for determining whether a subject has or is predisposed to developing a disease which is associated with IL-1 polymorphisms and assays for identifying therapeutics for treating and/or preventing the development of these diseases are provided.
Anti-Resorptive And Bone Building Dietary Supplements And Methods Of Use
David W. Krempin - Temecula CA, US Mary A. Murray - Irvine CA, US Yumei Lin - Long Beach CA, US Kevin W. Gellenbeck - Poway CA, US Silvia R. da Costa - Redondo Beach CA, US Leon M. Wilkins - North Andover MA, US Jatinder Rana - Grand Rapids MI, US John F. Rebhun - Greenville MI, US David J. Fast - Grand Rapids MI, US Laurie Krempin - Temecula CA, US
International Classification:
A61K 36/254 A61K 36/48 A61K 36/87 A61P 19/00
US Classification:
424728, 424757, 424766
Abstract:
Disclosed herein are dietary supplement compositions and methods for increasing or stimulating bone growth, decreasing or preventing bone resorption, increasing bone strength, improving bone structure, and improving bone architecture comprising a first composition comprising a combination of at least two of: quercetin, sp., sp. root, Siberian ginseng, , licorice, and ipriflavone, wherein the combination of the first composition increases bone morphogenic protein-2 gene, promoter or protein expression; and a second composition comprising an extract of pomegranate in combination with at least one of Siberian ginseng, , green tea, sp., grape seed, Dong Quai, and ipriflavone, wherein the combination of the second composition inhibits the expression of RANK-L.
Anti-Resorptive And Bone Building Dietary Supplements And Methods Of Use
David W. Krempin - Temecula CA, US Mary A. Murray - Irvine CA, US Yumei Lin - Long Beach CA, US Kevin W. Gellenbeck - Poway CA, US Silvia R. da Costa - Redondo Beach CA, US Leon M. Wilkins - North Andover MA, US Jatinder Rana - Grand Rapids MI, US John F. Rebhun - Greenville MI, US David J. Fast - Grand Rapids MI, US Laurie Krempin - Temecula CA, US
Disclosed herein are dietary supplement compositions and methods for increasing or stimulating bone growth and, decreasing or preventing bone resorption comprising a first composition comprising a combination of at least two of: quercetin, sp., sp. root, Siberian ginseng, , licorice, and ipriflavone, wherein the combination of the first composition increases BMP-2 gene expression, promoter activity, or protein expression; and a second composition comprising an extract of pomegranate in combination with at least one of Siberian ginseng, , green tea, sp., grape seed, Dong Quai, and ipriflavone, wherein the combination of the second composition inhibits the expression of RANK-L.
Diagnostics For Aging-Related Dermatologic Disorders
Kenneth S. Kornman - Newton MA, US Leon Wilkins - North Andover MA, US
Assignee:
INTERLEUKIN GENETICS, INC. - Waltham MA
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
The present invention provides methods for the early prediction of aging-related dermatologic conditions of including skin changes associated with intrinsic aging or skin damages caused by extrinsic aging such as photoaging. The present invention also provides kits for the early determination of the propensity to develop such disorder and conditions. The method consists of detecting the presence of one or more alleles of an IL-1 haplotype or pattern, specifically the IL-1RN (+2018) and the IL-1B (−511) loci. The presence of allele 2 at the IL-1RN (+2018) and the IL-1B (−511) loci indicates decreased risk for a early onset of aging related dermatologic conditions.
Robert Leon Wilkins (born 1963) is a United States district judge on the United States District Court for the District of Columbia. He was previously an attorney in ...
Name / Title
Company / Classification
Phones & Addresses
Leon Wilkins Principal
Cytoprocess Consulting Business Consulting Services
Aderans Research Institute 2003 - Jul 2013
Scientific Advisor
Cytoprocess Consulting 2003 - Jul 2013
Lead Consultant
Interleukin Genetics 2003 - Jul 2013
Senior Director Translational Science
Organogenesis Inc. Aug 1997 - Sep 2002
Vice President Technology Development and Manufacturing Support
Gillette Research Institute 1982 - 1988
Senior Scientist
Education:
Harvard Medical School 1979 - 1982
University of Nebraska - Lincoln 1975 - 1978
Doctorates, Doctor of Philosophy, Genetics, Biology
Merrimack College 1968 - 1972
Bachelors, Bachelor of Arts, Biology
Skills:
Cell Culture Cell Cell Biology Gmp Biotechnology Life Sciences In Vitro Clinical Trials R&D Fda Commercialization Clinical Development Technology Transfer Biopharmaceuticals Genomics Dna Protein Chemistry Medical Devices Validation Molecular Biology Microbiology Pharmaceutical Industry Quality System Genetics Immunology Assay Development Pcr Qpcr Lifesciences Product Development Biochemistry Glp Drug Discovery Stem Cells Flow Cytometry Sop Process Simulation Manufacturing Elisa Science Regulatory Affairs Standard Operating Procedure Cross Functional Team Leadership Process Improvement